Immature (undifferentiated) cells are on the left panel and cells that have differentiated in response to treatment with brequinar are on the right panel. Photo courtesy of Scadden Lab.

Simple compound could provide first new therapy for AML in four decades...

HSCI codirector David Scadden has been named a Fellow of the American Association for the Advancement of Science (AAAS). 

This year 391 members have been awarded this honor by AAAS because of their scientifically or socially distinguished efforts to advance science or its applications. New Fellows will be...

Photo courtesy of Vionnie Yu, Scadden Lab. 

Color-labeling helps Harvard researchers track the development and behavior of individual cells

By Hannah Robbins

Harvard Stem Cell Institute...

Startup Magenta Therapeutics licences technologies from Harvard, MGH, and Boston Children's that could transform treatment of blood diseases and immune disorders

Harvard University has completed a license agreement with Magenta Therapeutics, a new startup company launched in Cambridge, for a portfolio of technologies with the potential to transform blood stem cell transplants from a “treatment of last resort” into a safer, more efficient therapy for patients with blood diseases...

Researchers from Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found...

Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases

Using large-scale zebrafish drug-screening models, Harvard Stem...

Cells that are the body's first defense against infection may play role in developing embryo

2013 HSCI Internship Program participant Isaura Frost, who worked on this project, with her mentor postdoctoral fellow Virginie Esain,...

Research addresses hurdles to future transplant-based, gene-editing therapies that could help people with genetic blood diseases

HSCI scientists at Harvard's Department of Stem Cell and Regenerative Biology and the ...

A possible new approach to treating HIV/AIDS

Harvard Stem Cell Institute (HSCI) researchers at Massachusetts General (MGH) and Boston Children’s...

New genetic barcoding technology allows scientists to identify differences in origin between individual blood cells. (Image by: Emily Huang)

New technology that tracks the origin of blood cells challenges scientific dogma

A 7-year-...

Harvard/MIT team finds that killing cancer cells by disrupting their metabolism doesn’t harm normal cells

A study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant to shifts in their energy supply than their...

Discovery opens new possibilities for regenerative medicine

...

Finding in zebrafish may be clinically relevant for humans... Read more about Common mutation is culprit in acute leukemia relapse